Te-fu F. Weng

Taitung, TNQ, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Transforming Hemophilia Treatment With Novel Rebalancing Agents: Clinical Studies and Practical Perspectives.

Transforming Hemophilia Treatment With Novel Rebalancing Agents: Clinical Studies and Practical Perspectives.

Journal: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis

Published: September 03, 2026

Post-Graft Romiplostim Before Posttransplant Cyclophosphamide in Emergency Haploidentical Transplantation for Very Severe Aplastic Anemia.

Post-Graft Romiplostim Before Posttransplant Cyclophosphamide in Emergency Haploidentical Transplantation for Very Severe Aplastic Anemia.

Journal: Pediatric blood & cancer

Published: June 24, 2026

Post-Engraftment Kinetics of Cross-Reactive Cryptococcal Antigenemia in Disseminated Trichosporon asahii Infection After Haploidentical Peripheral Blood Stem Cell Transplantation.

Post-Engraftment Kinetics of Cross-Reactive Cryptococcal Antigenemia in Disseminated Trichosporon asahii Infection After Haploidentical Peripheral Blood Stem Cell Transplantation.

Journal: Transplant infectious disease : an official journal of the Transplantation Society

Published: June 23, 2026

Current Status of National Haemophilia Registries in the Asia-Pacific Region: An AHAD-AP Registry Committee Survey.

Current Status of National Haemophilia Registries in the Asia-Pacific Region: An AHAD-AP Registry Committee Survey.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: June 13, 2026

Umbilical Cord Blood Transplantation in Lesch-Nyhan Syndrome: A Case Report and Literature Review.

Umbilical Cord Blood Transplantation in Lesch-Nyhan Syndrome: A Case Report and Literature Review.

Journal: Cureus

Published: November 16, 2025

Real-World Assessment of rVIII-SingleChain for Prophylactic Treatment in People With Severe Hemophilia A in High-Resource Settings.

Real-World Assessment of rVIII-SingleChain for Prophylactic Treatment in People With Severe Hemophilia A in High-Resource Settings.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: October 16, 2025

Evaluating the Effectiveness of Prophylactic Strategies for Hemophilia A Management: A Real-World, Longitudinal Observational Study.

Evaluating the Effectiveness of Prophylactic Strategies for Hemophilia A Management: A Real-World, Longitudinal Observational Study.

Journal: Drugs - real world outcomes

Published: August 25, 2024

Patient and Caregiver Preferences for Hemophilia A Treatment in Taiwan: A Discrete Choice Experiment.

Patient and Caregiver Preferences for Hemophilia A Treatment in Taiwan: A Discrete Choice Experiment.

Journal: Value in health regional issues

Published: March 28, 2024

Biology and Therapeutic Properties of Mesenchymal Stem Cells in Leukemia.

Biology and Therapeutic Properties of Mesenchymal Stem Cells in Leukemia.

Journal: International journal of molecular sciences

Published: January 07, 2024

Efficacy, safety and cost of emicizumab prophylaxis in haemophilia A patients with inhibitors: A nationwide observational study in Taiwan.

Efficacy, safety and cost of emicizumab prophylaxis in haemophilia A patients with inhibitors: A nationwide observational study in Taiwan.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: June 12, 2023

Clinical Predictors and Prediction Models for rFVIII-Fc Half Life in Real-World People with Severe Hemophilia A.

Clinical Predictors and Prediction Models for rFVIII-Fc Half Life in Real-World People with Severe Hemophilia A.

Journal: Journal of clinical medicine

Published: January 29, 2023

Antithymocyte Globulin Plus Post-Transplant Cyclophosphamide Combination as an Effective Strategy for Graft-versus-Host Disease Prevention in Haploidentical Peripheral Blood Stem Cell Transplantation for Children with High-Risk Malignancies.

Antithymocyte Globulin Plus Post-Transplant Cyclophosphamide Combination as an Effective Strategy for Graft-versus-Host Disease Prevention in Haploidentical Peripheral Blood Stem Cell Transplantation for Children with High-Risk Malignancies.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: October 24, 2022

Showing 1-12 of 28

Last Updated: 09/26/2026